For PDFs of any of our publications please Email us
- Wang N, Agrawal A, Jørgensen NR & Gartland A (2018) P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis. Scientific Reports, 8(1). View this article in WRRO
- Steinberg J, Shah KM, Gartland A, Zeggini E & Wilkinson JM (2017) Effects of chronic cobalt and chromium exposure after metal-on-metal hip resurfacing: An epigenome-wide association pilot study. Journal of Orthopaedic Research, 35(10), 2323-2328. View this article in WRRO
- Ellegaard M, Agca C, Petersen S, Agrawal A, Kruse LS, Wang N, Gartland A, Jensen J-EB, Jørgensen NR & Agca Y (2017) Bone turnover is altered in transgenic rats overexpressing the P2Y2 purinergic receptor. Purinergic Signalling.
- Dastgheib SA, Gartland A, Tabei SMB, Omrani GR & Teare MD (2016) A Candidate Gene Association Study of Bone Mineral Density in an Iranian Population. Frontiers in Endocrinology, 7. View this article in WRRO
- Shah KM, Orton P, Mani N, Wilkinson JM & Gartland A (2016) Osteocyte physiology and response to fluid shear stress are impaired following exposure to cobalt and chromium: Implications for bone health following joint replacement.. Journal of Orthopaedic Research. View this article in WRRO
- Gartland A, Erler JT & Cox TR (2016) The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis. Journal of Bone Oncology. View this article in WRRO
- Proctor C & Gartland A (2016) Simulated Interventions to Ameliorate Age-Related Bone Loss Indicate the Importance of Timing. Frontiers in Endocrinology, 7. View this article in WRRO
- Varley I, Greeves JP, Sale C, Friedman E, Moran DS, Yanovich R, Wilson PJ, Gartland A, Hughes DC, Stellingwerff T, Ranson C, Fraser WD & Gallagher JA (2016) Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury. Purinergic Signalling, 12(1), 103-113.
- Cox TR, Gartland A & Erler JT (2016) Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis. Cancer Research, 76(2), 188-192.
- Cox TR, Schoof EM, Gartland A, Erler JT & Linding R (2015) Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropism. Data in Brief, 5, 621-625. View this article in WRRO
- Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, Bird D, Latif NA, Forrest H, Evans HR, Huggins ID, Lang G, Linding R, Gartland A & Erler JT (2015) The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature, 522(7554), 106-110. View this article in WRRO
- Shah KM, Wilkinson JM & Gartland A (2015) Cobalt and chromium exposure affects osteoblast function and impairs the mineralization of prosthesis surfaces in vitro. Journal of Orthopaedic Research, 33(11), 1663-1670. View this article in WRRO
- Agrawal A & Gartland A (2015) P2X7 receptors: role in bone cell formation and function. Journal of Molecular Endocrinology, 54(2), R75-R88.
- Shah KM, Quinn PD, Gartland A & Wilkinson JM (2015) Understanding the tissue effects of tribo-corrosion: Uptake, distribution, and speciation of cobalt and chromium in human bone cells. Journal of Orthopaedic Research, 33(1), 114-121.
- Giuliani AL, Colognesi D, Ricco T, Roncato C, Capece M, Amoroso F, Wang QG, De Marchi E, Gartland A, Di Virgilio F & Adinolfi E (2014) Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma. PLoS ONE, 9(9), e107224-e107224. View this article in WRRO
- Gartland A & Hocking LJ (2014) Editorial overview: Musculoskeletal: Are we on the road to personalised medicine in musculoskeletal diseases?. Curr Opin Pharmacol, 16, vii-ix.
- Wang N & Gartland A (2014) Targeting P2 receptors–current progress in treating musculoskeletal diseases.. Curr Opin Pharmacol, 16, 122-126. View this article in WRRO
- Wang N, Robaye B, Gossiel F, Boeynaems J-M & Gartland A (2014) The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development.. FASEB J, 28(5), 2249-2259. View this article in WRRO
- Biver G, Wang N, Gartland A, Orriss I, Arnett TR, Boeynaems JM & Robaye B (2013) Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes. Stem Cells, 31(12), 2747-2758. View this article in WRRO
- Wang N & Gartland A (2013) Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion: Presented by: Maria P. Abbracchio. Purinergic Signalling, 9(3), 281-284. View this article in WRRO
- Gartland A (2013) Purinergic ADP receptors: from block buster blood drugs to bone-disease busters. IBMS BoneKEy, 10.
- Wang N, Rumney RMH, Yang L, Robaye B, Boeynaems J-M, Skerry TM & Gartland A (2013) The P2Y13 receptor regulates extracellular ATP metabolism and the osteogenic response to mechanical loading.. J Bone Miner Res, 28(6), 1446-1456. View this article in WRRO
- Gheryani N, Coffelt SB, Gartland A, Rumney RMH, Kiss-Toth E, Lewis CE, Tozer GM, Greaves DR, Dear TN & Miller G (2013) Generation of a novel mouse model for the inducible depletion of macrophages in vivo.. Genesis, 51(1), 41-49.
- Syberg S, Petersen S, Beck Jensen JE, Gartland A, Teilmann J, Chessell I, Steinberg TH, Schwarz P & Jorgensen NR (2012) Genetic background strongly influences the bone phenotype of P2X7 receptor knockout mice. Journal of Osteoporosis, 2012. View this article in WRRO
- Cox TR, Gartland A & Erler JT (2012) The pre-metastatic niche: is metastasis random[quest]. BoneKEy Rep, 1(5).
- Gartland A, Skarratt KK, Hocking LJ, Parsons C, Stokes L, Jørgensen NR, Fraser WD, Reid DM, Gallagher JA & Wiley JS (2012) Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women.. Eur J Hum Genet, 20(5), 559-564. View this article in WRRO
- Gartland A (2012) P2X receptors in bone. Wiley Interdisciplinary Reviews: Membrane Transport and Signaling, 1(2), 221-227.
- Jørgensen NR, Husted LB, Skarratt KK, Stokes L, Tofteng CL, Kvist T, Jensen J-EB, Eiken P, Brixen K, Fuller S, Clifton-Bligh R, Gartland A, Schwarz P, Langdahl BL & Wiley JS (2012) Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. European Journal of Human Genetics.
- Rumney RMH, Wang N, Agrawal A & Gartland A (2012) Purinergic signalling in bone.. Front Endocrinol (Lausanne), 3, 116. View this article in WRRO
- Dillon JP, Waring-Green VJ, Taylor AM, Wilson PJM, Birch M, Gartland A & Gallagher JA (2012) Primary human osteoblast cultures.. Methods Mol Biol, 816, 3-18.
- Gartland A, Rumney RMH, Dillon JP & Gallagher JA (2012) Isolation and culture of human osteoblasts.. Methods Mol Biol, 806, 337-355.
- Agrawal A, Gallagher JA & Gartland A (2012) Human osteoclast culture and phenotypic characterization.. Methods Mol Biol, 806, 357-375.
- Wang N, Robaye B, Agrawal A, Skerry TM, Boeynaems J-M & Gartland A (2012) Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.. Mol Endocrinol, 26(1), 142-152. View this article in WRRO
- Gartland A, Orriss IR, Rumney RMH, Bond AP, Arnett T & Gallagher JA (2012) Purinergic signalling in osteoblasts.. Front Biosci (Landmark Ed), 17, 16-29.
- Rumney RMH, Sunters A, Reilly GC & Gartland A (2012) Application of multiple forms of mechanical loading to human osteoblasts reveals increased ATP release in response to fluid flow in 3D cultures and differential regulation of immediate early genes.. J Biomech, 45(3), 549-554.
- Orriss IR, Wang N, Burnstock G, Arnett TR, Gartland A, Robaye B & Boeynaems J-M (2011) The P2Y(6) receptor stimulates bone resorption by osteoclasts.. Endocrinology, 152(10), 3706-3716. View this article in WRRO
- Andrews RE, Shah KM, Wilkinson JM & Gartland A (2011) Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health.. Bone, 49(4), 717-723. View this article in WRRO
- Wesselius A, Bours MJL, Agrawal A, Gartland A, Dagnelie PC, Schwarz P & Jorgensen NR (2011) Role of purinergic receptor polymorphisms in human bone. FRONT BIOSCI-LANDMRK, 16, 2572-2585.
- Orriss I, Syberg S, Wang N, Robaye B, Gartland A, Jorgensen NR, Arnett T & Boeynaems JM (2011) Bone phenotypes of P2 receptor knockout mice. Frontiers in Bioscience(S3), 1038-1046.
- Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A & Erler JT (2011) LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.. Cancer Res, 71(5), 1561-1572.
- Gartland A (2011) Fast Facts: Osteoporosis, 6th edition. PERSPECT PUBLIC HEAL, 131(1), 48-48.
- Agrawal A, Buckley KA, Bowers K, Gaw A, Furber M, Gallagher JA & Gartland A (2010) The Effect of Different P2X(7) Receptor Antagonists on the Formation and Function of Human Osteoclast in vitro. PURINERG SIGNAL, 6(1), 139-140.
- Agrawal A, Buckley KA, Bowers K, Furber M, Gallagher JA & Gartland A (2010) The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro. Purinergic Signalling, 6(3), 307-315.
- Gartland A, Mason-Savas A, Yang M, MacKay CA, Birnbaum MJ & Odgren PR (2009) Septoclast deficiency accompanies postnatal growth plate chondrodysplasia in the toothless (tl) osteopetrotic, colony-stimulating factor-1 (CSF-1)-deficient rat and is partially responsive to CSF-1 injections. American Journal of Pathology, 175(6), 2668-2675.
- Chan BY, Gartland A, Wilson PJM, Buckley KA, Dillon JP, Fraser WD & Gallagher JA (2007) PPAR agonists odulate human osteoclast formation and activity in vitro. BONE, 40(1), 149-159.
- Gartland A, Mechler J, Mason-Savas A, MacKay CA, Mailhot G, Marks SC & Odgren PR (2005) In vitro chondrocyte differentiation using costochondral chondrocytes as a source of primary rat chondrocyte cultures: An improved isolation and cryopreservation method. Bone, 37(4), 530-544.
- Devraj K, Bonassar LJ, MacKay CA, Mason-Savas A, Gartland A & Odgren PR (2004) A New Histomorphometric Method to Assess Growth Plate Chondrodysplasia and Its Application to the Toothless ( tl, Csf1 null Osteopetrotic Rat. Connective Tissue Research, 45(1), 1-10.
- Gartland A, Buckley KA, Bowler WB & Gallagher JA (2003) Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.. Calcif Tissue Int, 73(4), 361-369.
- Gartland A, Buckley KA, Hipskind RA, Perry MJ, Tobias JH, Buell G, Chessell I, Bowler WB & Gallagher JA (2003) Multinucleated osteoclast formation in vivo and in vitro by P2X(7) receptor-deficient mice. CRIT REV EUKAR GENE, 13(2-4), 243-253.
- Gartland A, Buckley KA, Hipskind RA, Bowler WB & Gallagher JA (2003) P2 receptors in bone – Modulation of osteoclast formation and activity via P2X(7) activation. CRIT REV EUKAR GENE, 13(2-4), 237-242.
- Odgren PR, Philbrick WM & Gartland A (2003) Perspective osteoclastogenesis and growth plate chondrocyte differentiation: Emergence of convergence. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 13(2-4), 181-193.
- Buckley KA, Hipskind RA, Gartland A, Bowler WB & Gallagher JA (2002) Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.. Bone, 31(5), 582-590.
- Bowler WB, Buckley KA, Gartland A, Hipskind RA, Bilbe G & Gallagher JA (2001) Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone, 28(5), 507-512.
- Gartland A, Hipskind RA, Gallagher JA & Bowler WB (2001) Expression of a P2X7 receptor by a subpopulation of human osteoblasts.. J Bone Miner Res, 16(5), 846-856.
The Gartland Lab 